AMAGUnknown
AMAG PHARMACEUTICALS, INC. Insider Trading Activity
Every SEC Form 4 insider transaction reported for AMAG PHARMACEUTICALS, INC. (AMAG), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud Research Team · SEC Form 4 & insider trading data analysts
Last updated:
Quick Answer
Are AMAG insiders buying or selling?
AMAG PHARMACEUTICALS, INC. insiders reported 10 open-market buys ($11.4M) and 4 sells ($60.2M) across 14 Form 4 filings — a net selling position of $48.8M.
Source: SEC EDGAR Form 4
Key Statistics (as of Oct 5, 2020)
Total Form 4 filings
14
SEC EDGAR
Insider filers
6
Insider buys (10)
$11.4M
Insider sells (4)
$60.2M
Insider sentiment
Net sellingNet insider flow of $48.8M in net selling.
Recent AMAG insider transactions
| Date | Insider | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Oct 5, 2020 | Camber Capital Management LP | 10% Owner | Sale | 4.4M | $13.57 | $59.6M |
| Mar 18, 2020 | Steven Boyd | 10% Owner | Purchase | 24.0K | $4.87 | $116.9K |
| Feb 27, 2020 | Steven Boyd | 10% Owner | Purchase | 36.0K | $8.29 | $298.4K |
| Jan 28, 2020 | Steven Boyd | 10% Owner | Purchase | 90.0K | $9.61 | $865.2K |
| Jan 13, 2020 | Steven Boyd | 10% Owner | Purchase | 18.0K | $11.57 | $208.3K |
| Aug 9, 2019 | Steven Boyd | 10% Owner | Purchase | 300.0K | $7.33 | $2.2M |
| Aug 9, 2019 | Camber Capital Management LP | 10% Owner | Purchase | 385.0K | $7.87 | $3.0M |
| Jun 27, 2019 | Steven Boyd | 10% Owner | Purchase | 498.0K | $8.87 | $4.4M |
| May 29, 2019 | Julie Krop | Chief Medical Officer | Purchase | 10.0K | $9.91 | $99.1K |
| May 9, 2019 | William K Heiden | President & CEO | Purchase | 10.0K | $10.70 | $107.0K |
| May 9, 2019 | Elizabeth Scott Bolgiano | Chief Human Resources Officer | Purchase | 5.0K | $10.93 | $54.6K |
| Mar 11, 2019 | Joseph Vittiglio | EVP, General Counsel | Sale | 1.4K | $14.01 | $20.0K |
| Aug 8, 2018 | William K Heiden | President & CEO | Sale | 5.0K | $25.00 | $125.0K |
| Jun 5, 2018 | William K Heiden | President & CEO | Sale | 20.0K | $25.00 | $500.0K |
Showing the 14 most recent of 14 Form 4 filings for AMAG PHARMACEUTICALS, INC..
Most active AMAG insiders
- Steven Boyd6 filings
- William K Heiden3 filings
- Camber Capital Management LP2 filings
- Elizabeth Scott Bolgiano1 filing
- Joseph Vittiglio1 filing
Ask anything about AMAG insider activity
Use Trabud's AI agent to query AMAG PHARMACEUTICALS, INC.'s Form 4 history in plain English — "Show me AMAG CEO purchases this year" or compare it against any other ticker.
Open the AI agentAMAG insider trading FAQ
Are AMAG PHARMACEUTICALS, INC. insiders buying or selling?
Across 14 SEC Form 4 filings, AMAG PHARMACEUTICALS, INC. (AMAG) insiders reported 10 open-market purchases totaling $11.4M and 4 sales totaling $60.2M. That is a net selling position of $48.8M.
How many insiders trade AMAG stock?
6 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for AMAG PHARMACEUTICALS, INC.. The most recent filing was accepted on Oct 5, 2020.
Where does Trabud get AMAG insider trading data?
All AMAG insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.
Looking for another company? Browse all tracked companies.